Osaic Holdings
MGRX icon

Osaic Holdings’s Mangoceuticals MGRX Stock Holding History

Osaic Holdings’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18K Buy
3,285
+400
+14% +$192 ﹤0.01% 7214
2025
Q4 		$2.13K Hold
2,885
– – ﹤0.01% 7075
2025
Q3 		$6.09K Hold
2,885
– – ﹤0.01% 6642
2025
Q2 		$4.38K Hold
2,885
– – ﹤0.01% 6609
2025
Q1 		$5.63K Buy
+2,885
New +$10.4K ﹤0.01% 6112

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Osaic Holdings's MGRX Position: Q1 2026 in Review

Osaic Holdings increased its Mangoceuticals (MGRX) stake by 14% in Q1 2026, buying an estimated $192 and bringing the position to 3,285 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #7214.

Osaic Holdings first reported a position in MGRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.09K in Q3 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Osaic Holdings held 3,285 shares of Mangoceuticals worth $1.18K as of Q1 2026.
  • Osaic Holdings bought 400 Mangoceuticals shares in Q1 2026, an estimated $192.
  • Mangoceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7214 holding.
  • Osaic Holdings first reported a position in Mangoceuticals in Q1 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Mangoceuticals position peaked at $6.09K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.